10X Genomics’ SWOT analysis: stock faces profitability test

FierceBiotechMerck inks Keytruda supply pact to support Exelixis’ colorectal cancer trial

PharmaVoiceSummer reads with unexpected lessons for biopharma leaders

BioWorldShanghai Meiyue Biotech discloses new EHMT2 inhibitors

BioWorldConvalife Pharmaceuticals discovers new CFB inhibitors

BioWorldKimia Therapeutics patents new DHX9 inhibitors

BioWorldNew PROTACs reported in Prelude Therapeutics patent

BioWorldBundibugyo is harsh reminder of need for broad vaccine strategies

LabiotechRAS inhibition enters its second wave

FierceBiotechLauxera Capital Partners raises a hefty €520M for health, medtech companies

BioPharma DiveRelay drug shows early promise against rare blood vessel diseases

FierceBiotechHerantis taps Indivi for digital biomarker tech in Parkinson’s disease trial

Endpoints NewsNourish raises $100M for virtual nutrition care